Clinical Trial: Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors

U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07086768) titled 'Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors' on July 18.

Brief Summary: This is a study that will enroll patients with cancer who have tumors that may have spread. The patients will know what medication they are being given.

There will be 2 parts to the study. For the first part of the study only one medication will be taken, and the dose changed to a higher dose over time.

In the second part of the study tow medications will be taken and the dose of the medication may be changed to a higher dose.

Study Start Date: Aug. 07

Study Type: I...